Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Immunovant, Inc.
IMVT
Segment Reporting, Other Segment Item, Amount
Segment Reporting, Other Segment Item, Amount at other companies
ConocoPhillips
COP
$7.45B
+42.3%
PRA Group
PRAA
$35.48M
-6.5%
Matthews International
MATW
-$15.63M
-883%
Collegium Pharmaceutical, Inc.
COLL
$25.48M
+4,316%
Radiant Logistics
RLGT
-$271K
-113%
Microbot Medical
MBOT
$557K
+7.3%
Segments
By segment
See full
Reportable Segment
-$3.64M
—
Other financials
Income statement
See full
Net income
-$147.9M
-38.9%
EPS (diluted)
-$0.73
-15.9%
Balance sheet
See full
Cash & equivalents
$902.1M
+26.4%
Total debt
$72.0K
-26.5%
Total equity
$852.6M
+20.5%
Total assets
$957.0M
+23.3%
Cash flow
See full
Operating cash flow
-$95.1M
+14.1%
CapEx
$8.0K
-96.0%
Free cash flow
-$95.1M
+14.2%
Valuation
See full
Market cap
$8.21B
+201%
Enterprise value
$7.31B
+89.7%
Returns & leverage
See full
Return on equity
-64.8%
+2.5pp
Debt / equity
0×
0.0×
Current ratio
9.1×
-2.1×
Watchlist
Screener
Filings
Earnings
Charts